Periodic PSA-based screening in men 55 to 69 years of age reduced prostate cancer mortality

Annals of Internal Medicine

Volumn 157, Issue 2, 2012, Pages

  Hoffman, Richard M ^a  

^a Department of Radiology and Nuclear Medicine Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 84863966351     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-2-201207170-02004     Document Type: Article

References (7)

1. Chou R, LeFevre ML. JAMA. 2011;306:2721-2.
2. Schröder FH, Hugosson J, Roobol MJ, et al; ERSPC Investigators. N Engl J Med. 2009;360:1320-8.
3. Andriole GL, Crawford ED, Grubb RL 3rd et al; PLCO Project Team. J Natl Cancer Inst. 2012;104:125-32.
4. Moyer VA; US Preventive Services Task Force. Ann Intern Med. 2012; 156:880-91.
5. Prasad SM, Drazer MW, Huo D, Hu JC, Eggener SE. JAMA. 2012;307: 1692-4.
6. Loeb S, Vonesh EF, Metter EJ, et al. J Clin Oncol. 2011;29:464-7.
7. Wolf AM, Wender RC, Etzioni RB, et al; American Cancer Society Prostate Cancer Advisory Committee. CA Cancer J Clin. 2010;60:70-98.